[1]
Poudyal, B.S., Sapkota, B., Shrestha, G.S., Thapalia, S., Gyawali, B. and Tuladhar, S. 2016. Safety and Efficacy of Azathioprine as a Second Line Therapy for Primary Immune Thrombocytopenic Purpura. Journal of Nepal Medical Association. 55, 203 (Sep. 2016), 16–21. DOI:https://doi.org/10.31729/jnma.2832.